biostudies-literatureSmith ESNational Cancer InstituteNCI NIH HHS882-890https://www.ebi.ac.uk/biostudies/studies/S-EPMC9256804biostudies-literatureUnknown32(7)<h4>Objective</h4>To assess potential predictive variables for nodal metastasis and survival outcomes in patients with newly diagnosed, low-grade endometrial stromal sarcoma.<h4>Methods</h4>We performed a single-institution, retrospective analysis of consecutive patients with newly diagnosed, low-grade endometrial stromal sarcoma who presented between January 1, 1980 and December 31, 2019 and underwent hysterectomy at our institution or presented within 3 months of primary surgery elsewhere before recurrence. Patients who presented to our institution only at recurrence were excluded. Patients with <3 months of follow-up were excluded from survival analyses.<h4>Results</h4>We identified 127 consecutive patients for analysis. Median age at diagnosis was 48 years (range 19-88 years); 91 (74.6International journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyPrimary characteristics and outcomes of newly diagnosed low-grade endometrial stromal sarcoma.PMC9256804P30 CA008748Mueller JJSmith ESJansen CAbu-Rustum NRHensley MLChiang SMiller KMAlektiar KMLeitao MMfalsePrimary characteristics and outcomes of newly diagnosed low-grade endometrial stromal sarcoma.<h4>Objective</h4>To assess potential predictive variables for nodal metastasis and survival outcomes in patients with newly diagnosed, low-grade endometrial stromal sarcoma.<h4>Methods</h4>We performed a single-institution, retrospective analysis of consecutive patients with newly diagnosed, low-grade endometrial stromal sarcoma who presented between January 1, 1980 and December 31, 2019 and underwent hysterectomy at our institution or presented within 3 months of primary surgery elsewhere before recurrence. Patients who presented to our institution only at recurrence were excluded. Patients with <3 months of follow-up were excluded from survival analyses.<h4>Results</h4>We identified 127 consecutive patients for analysis. Median age at diagnosis was 48 years (range 19-88 years); 91 (74.62022-01-01T00:00:00Z2022 Jul2025-04-21T22:07:41.191Z2025-04-21T22:07:41.191ZS-EPMC92568043564100410.1136/ijgc-2022-003383